GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alzinova AB (OSTO:ALZ) » Definitions » Equity-to-Asset

Alzinova AB (OSTO:ALZ) Equity-to-Asset : 0.92 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Alzinova AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Alzinova AB's Total Stockholders Equity for the quarter that ended in Dec. 2023 was kr113.86 Mil. Alzinova AB's Total Assets for the quarter that ended in Dec. 2023 was kr123.19 Mil. Therefore, Alzinova AB's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.92.

The historical rank and industry rank for Alzinova AB's Equity-to-Asset or its related term are showing as below:

OSTO:ALZ' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.92   Med: 0.95   Max: 0.97
Current: 0.92

During the past 8 years, the highest Equity to Asset Ratio of Alzinova AB was 0.97. The lowest was 0.92. And the median was 0.95.

OSTO:ALZ's Equity-to-Asset is ranked better than
89.75% of 1561 companies
in the Biotechnology industry
Industry Median: 0.67 vs OSTO:ALZ: 0.92

Alzinova AB Equity-to-Asset Historical Data

The historical data trend for Alzinova AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alzinova AB Equity-to-Asset Chart

Alzinova AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.93 0.95 0.97 0.95 0.92

Alzinova AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 0.95 0.96 0.94 0.92

Competitive Comparison of Alzinova AB's Equity-to-Asset

For the Biotechnology subindustry, Alzinova AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alzinova AB's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzinova AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Alzinova AB's Equity-to-Asset falls into.



Alzinova AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Alzinova AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=113.858/123.189
=0.92

Alzinova AB's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=113.858/123.189
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alzinova AB  (OSTO:ALZ) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Alzinova AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Alzinova AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Alzinova AB (OSTO:ALZ) Business Description

Traded in Other Exchanges
Address
Pepparedsleden 1, Molndal, SWE, SE-431 83
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is also engaged in development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody. The product is in clinical development as a therapeutic vaccine for the treatment of Alzheimer's.

Alzinova AB (OSTO:ALZ) Headlines

No Headlines